Can K-ras gene mutation be utilized as prognostic biomarker for colorectal cancer patients receiving chemotherapy? A meta-analysis and systematic review.
<h4>Introduction</h4>K-ras gene mutations were common in colorectal patients, but their relationship with prognosis was unclear.<h4>Objective</h4>Verify prognostic differences between patient with and without mutant K-ras genes by reviewing the published evidence.<h4>Me...
Saved in:
Main Authors: | Yuan-Yi Rui, Dan Zhang, Zong-Guang Zhou, Cun Wang, Lie Yang, Yong-Yang Yu, Hai-Ning Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0077901 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches
by: Osman Sütcüoğlu, et al.
Published: (2025-06-01) -
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm
by: Chung Hoow Kok, et al.
Published: (2025-08-01) -
Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study
by: Mai O Kadry, et al.
Published: (2024-12-01) -
Prognostic and predictive molecular biomarkers of colorectal cancer
by: A. D. Shakhmatova, et al.
Published: (2025-06-01) -
The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis.
by: Gholamreza Safaee Ardekani, et al.
Published: (2012-01-01)